Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Priyanka Ingle, MD (Intl), MSc, PhD

Director, Global Regulatory Strategy, RA
Bayer Pharmaceuticals

Dr. Priyanka Ingle is currently with Bayer Pharmaceuticals as a Global Regulatory Strategist (GRS) since 2020, and has successfully lead US and global regulatory strategy, planning, submissions, and HA interactions. She is instrumental as US or Global regulatory lead for programs in various TAs and leading them further in development. In her current role she collaborates and contributes with global teams to support clinical development plan, global target label and as Lead GRS coordinates regional regulatory activities. Recently, she received Bayer Science Fellow award and was nominated for HBA Rising Star. Prior to working with Bayer, Dr. Ingle contributed as Translational Clinical Pharmacologist supporting Clinical Development and Regulatory Affairs with CRC Pharmaceuticals, New Jersey, USA, for 5 years. Dr. Ingle was Assistant Professor with Maharashtra University of Health Sciences at KEM Hospital in Infectious Disease Department, Mumbai, India for 3 years. Dr. Ingle is a Physician-Scientist, trained medical graduate with Master and PhD in Pharmaceutical Medicine and experienced in medical practice, academia, and industry for over a decade.

Disclosure information not submitted.

Presentation(s):